Kubota Pharmaceutical Holdings Co., Ltd. provided consolidated earnings guidance for the fiscal year ending December 31, 2022. For the year, the company expects operating loss of JPY 2,000 million, net loss of JPY 2,000 million and basic loss per share of JPY 43.61.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70 JPY | 0.00% | +2.94% | -12.50% |
1st Jan change | Capi. | |
---|---|---|
-12.50% | 25.34M | |
+25.23% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.89% | 233B | |
+5.27% | 201B | |
-10.27% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- 4596 Stock
- News Kubota Pharmaceutical Holdings Co., Ltd.
- Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022